Elanco Director Exercises Stock Options
Ticker: ELAN · Form: 4 · Filed: 2026-04-02T16:02:28-04:00
Sentiment: neutral
Topics: insider-transaction, stock-options, form-4
Related Tickers: ELAN
TL;DR
Elanco director Anand Kapila bought 1,100 shares for $18,976 via options on 3/31.
AI Summary
On March 31, 2026, Anand Kapila, a director at Elanco Animal Health Inc., reported a change in beneficial ownership of securities. The filing details the acquisition of 1,100 shares of common stock through the exercise of options, with a reported value of $18,976.
Why It Matters
This filing indicates a director's belief in the company's value, as they exercised options to acquire more stock.
Risk Assessment
Risk Level: low — This is a routine Form 4 filing indicating insider stock option exercise, not a significant event impacting the company's overall risk profile.
Key Numbers
- 1,100 — Shares Acquired (Number of shares obtained by director via option exercise.)
- $18,976 — Transaction Value (Monetary value of the shares acquired through option exercise.)
Key Players & Entities
- Anand Kapila (person) — Director of Elanco Animal Health Inc.
- Elanco Animal Health Inc (company) — Issuer of the securities
- $18,976 (dollar_amount) — Value of the stock acquired
- 1,100 shares (stock_shares) — Number of shares acquired
- March 31, 2026 (date) — Date of the transaction
FAQ
Who is Anand Kapila?
Anand Kapila is a director at Elanco Animal Health Inc. who reported a change in beneficial ownership.
What type of transaction occurred?
Anand Kapila exercised stock options to acquire shares of Elanco Animal Health Inc. common stock.
How many shares were acquired?
1,100 shares of common stock were acquired.
What was the date of the transaction?
The transaction occurred on March 31, 2026.
What is the reported value of the acquired shares?
The reported value of the acquired shares is $18,976.
From the Filing
EDGAR Filing Documents for 0001679166-26-000004 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001679166-26-000004 Filing Date 2026-04-02 Accepted 2026-04-02 16:02:28 Documents 1 Period of Report 2026-03-31 Document Format Files Seq Description Document Type Size 1 form4-04022026_080421.html 4 1 form4-04022026_080421.xml 4 4900 Complete submission text file 0001679166-26-000004.txt 6265 Mailing Address 303 INTERNATIONAL CIRCLE SUITE 200 HUNT VALLEY MD 21030 Business Address Anand Kapila K ( Reporting ) CIK : 0001679166 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 26833193 Mailing Address 450 ELANCO CIRCLE INDIANAPOLIS IN 46221 Business Address 450 ELANCO CIRCLE INDIANAPOLIS IN 46221 877-352-6261 Elanco Animal Health Inc ( Issuer ) CIK : 0001739104 (see all company filings) EIN. : 825497352 | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)